发明名称 |
Combination therapy with gemcitabine and ZD6126 |
摘要 |
The present invention relates to a method for the production of a vascular damaging effect in a warm-blooded animal such as a human which is optionally being treated with ionising radiation, particularly a method for the treatment of a cancer involving a solid tumour, which comprises the administration of ZD6126 in combination with gemcitabine; to a pharmaceutical composition comprising ZD6126 and gemcitabine; to a combination product comprising ZD6126 and gemcitabine for use in a method of treatment of a human or animal body by therapy; to a kit comprising ZD6126 and gemcitabine; and to the use of ZD6126 and gemcitabine in the manufacture of a medicament for use in the production of a vascular damaging effect in a warm-blooded animal such as a human which is optionally being treated with ionising radiation. |
申请公布号 |
ZA200502759(B) |
申请公布日期 |
2006.06.28 |
申请号 |
ZA20050002759 |
申请日期 |
2005.04.05 |
申请人 |
ANGIOGENE PHARMACEUTICALS LTD |
发明人 |
ALAN BARGE |
分类号 |
A61K;A61K31/661;A61K31/7068;A61P;A61P35/00 |
主分类号 |
A61K |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|